Where does Avalyn Pharma Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Avalyn Pharma Inc. ranks #20,792 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Avalyn Pharma Inc. hold?

Avalyn Pharma Inc. holds 13 US utility patents granted between 2018 and 2025, spanning 3 technology areas.

What is Avalyn Pharma Inc.'s Innovation Score?

Avalyn Pharma Inc. has an Innovation Score of 36.8 out of 100 (top 45% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Avalyn Pharma Inc.'s patent grant rate increasing or decreasing?

Avalyn Pharma Inc.'s recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Avalyn Pharma Inc.'s patents?

Avalyn Pharma Inc.'s patents average 13.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Avalyn Pharma Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Avalyn Pharma Inc.

Q: What technology areas does Avalyn Pharma Inc. focus on?

Avalyn Pharma Inc.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 13 patents. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 13 granted patents across 3 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Avalyn ranks #20,792 of 50,000 tracked US assignees by granted-patent volume, with 13 patents across 3 technology areas.

#20,792
of 50,000 US assignees by volume: Top 45%
by Innovation Score (36.8/100): 13.7
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20792 · US Corporation #20,792 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #20,792/50,000
PHOTO-FINISH Aboca S p A Società…
CPC-NARROW A61K · 3 areas
INNOV-THIN 36.8/100
CLAIMS-RICH 13.7 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Aboca S.p.a. Società Agricola (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Avalyn Pharma · this assignee

37
3D Lighting Innovati… · lowest

7

What this shows Avalyn's Innovation Score is 36.8/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Avalyn's grants concentrate

Avalyn Pharma Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). Peak complete grant year is 2018 (3 grants) versus a trough of 1 in 2020. By volume, Avalyn sits between ATOS France and Accuweather, Inc..

ATOS France

13
Atrion Medical Pr…

13
Aurelia Holdings

13
Aurora Insight

13
AVIO S P A

13
Aboca S p A Socie…

13
Acleap Power

13
Accuweather

13
Avalyn Pharma ◀

13

What this shows Avalyn holds 13 patents at rank #20,737, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Avalyn

By rank, the assignees closest to #20,737 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Avalyn's primary technology class.

Avalyn's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 45% higher than 55% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Avalyn Pharma Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	3	23.1%
2020	1	7.7%
2021	2	15.4%
2022	2	15.4%
2023	1	7.7%
2024	3	23.1%
2025partial year	1	7.7%

Which technologies does Avalyn Pharma Inc. patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 13

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 10

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 7

Top 3 of 3 technology areas

Where it ranks

Overall rank by patents

#20,792

of 50,000 tracked assignees

Innovation Score

36.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.